1.Dominguez, MA, et al. Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital. Journal of Clinical and Microbiology 1994; 32: 2081–2087.
2.Manzur, A, et al. Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonisation among residents in community long-term-care facilities in Spain. Clinical Microbiology and Infection 2008; 14: 867–872.
3.Olona-Cabases, M, et al. Methicillin-resistant Staphylococcus aureus: a four-year experience in a spinal cord injury unit in Spain. Spinal Cord 1996; 34: 315–319.
4.Cretnik, TZ, et al. Prevalence and nosocomial spread of methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infection Control and Hospital Epidemiology 2005; 26: 184–190.
5.Barr, B, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonisation among older residents of care homes in the United Kingdom. Infection Control and Hospital Epidemiology 2007; 28: 853–859.
6.Talon, DR, Bertrand, X. Methicillin-resistant Staphylococcus aureus in geriatric patients: usefulness of screening in a chronic-care setting. Infection Control and Hospital Epidemiology 2001; 22: 505–509.
7.O'Sullivan, NP, Keane, CT. The prevalence of methicillin-resistant Staphylococcus aureus among the residents of six nursing homes for the elderly. Journal of Hospital Infection 2000; 45: 322–329.
8.von Baum, H, et al. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infection Control and Hospital Epidemiology 2002; 23: 511–515.
9.Pujol, M, et al. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 96–102.
10.Corbella, X, et al. S. aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit. European Journal of Clinical Microbiology and Infectious Diseases 1997; 16: 351–357.
11.Pujol, M, et al. Nosocomial S. aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. American Journal of Medicine 1996; 100: 509–516.
12.Murder, RR, et al. Methicillin-resistant staphylococcal colonisation and infection in a long-term care facility. Annals of Internal Medicine 1991; 114: 107–112.
13.Bradley, SF. Methicillin-resistant Staphylococcus aureus: long-term care concerns. American Journal of Medicine 1999; 106: 2S–10S.
14.Stone, ND, et al. Importance of bacterial burden among methicillin-resistant Staphylococcus aureus carriers in a long-term care facility. Infection Control and Hospital Epidemiology 2008; 29: 143–148.
15.Rodríguez-Baño, J, et al. Surveillance and control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A GEIH-SEIMC and SEMPSPH consensus document. Enfermedades Infecciosas y Microbiología Clínica 2008; 26: 285–298.
16.Manzur, A, et al. The natural history of methicillin-resistant Staphylococcus aureus colonization among residents in community long-term-care facilities in Spain. Journal of Hospital Infection 2010; 76: 215–219.
17.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th Informational Supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2006.
18.Cooper, BS, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences USA 2004; 101: 10223–10228.
19.Carleton, HA, et al. Community-adapted methicillin-resistant Staphylococcus aureus: population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases 2004; 190: 1730–1738.
20.Manzur, A, et al. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infection at hospital admission. Journal of Hospital Infection 2007; 66: 135–141.
21.Gavalda, L, et al. Comparative cost of selective screening to prevent transmission of methicillin resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. Infection Control and Hospital Epidemiology 2006; 27: 1264–1266.
22.Ruiz de Gopegui, E, et al. Epidemiological relatedness of methicillin-resistant Staphylococcus aureus from a tertiary hospital and a geriatric institution in Spain. Clinical Microbiology and Infection 2004; 10: 339–342.
23.Datta, R, Huang, S. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clinical Infectious Diseases 2008; 47: 176–181.
24.Vandenbergh, MFQ, et al. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. Journal of Clinical Microbiology 1999; 37: 3133–3140.
25.Raab, U, et al. Prevalence of and risk factors for carriage of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus among residents and staff of a German nursing home. Infection Control and Hospital Epidemiology 2006; 27: 208–211.
26.Wagenlehner, F, et al. Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. Journal of Hospital Infection 2007; 67: 114–120.
27.Kerttula, AM, et al. Molecular epidemiology of an outbreak caused by methicillin-resistant Staphylococcus aureus in a healthcare ward and associated nursing home. Journal of Clinical Microbiology 2005; 43: 6161–6163.
28.Vindel, A, et al. Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. Journal of Clinical Microbiology 2009; 47: 1620–1627
29.Rodríguez-Baño, J, et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain. Clinical Microbiology and Infection 2009; 15: 1111–1118
30.Suetens, C, et al. Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. Journal of American Geriatric Society 2006; 54: 1854–1860.
31.Mody, L, et al. Epidemiology of Staphylococcus aureus colonisation in nursing home residents. Clinical Infectious Diseases 2008; 46: 1368–1373.
32.Mahoney, F, Barthel, DW. Functional evaluation: the Barthel index. Maryland State Medical Journal 1965; 14: 61–65.
33.Mody, L, et al. Preventing infections in nursing homes: a survey of infection control practices in southeast Michigan. American Journal of Infection Control 2005; 33: 489–492.
34.Manzur, A, Pujol, M. Impact and control of methicillin-resistant Staphylococcus aureus (MRSA) in long-term care facilities. Revista Española de Geriatría y Gerontología 2008;43: 235–238.
35.Kreman, T, et al. Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infection Control and Hospital Epidemiology 2005; 26: 811–815.
36.Manzur, A, Gudiol, F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clinical and Microbiology Infection 2009; 15: S26–30.